TAILOR: Phase III trial comparing erlotinib with docetaxel in the second-line treatment of NSCLC patients with wild-type (wt) EGFR.

被引：19

作者：

Garassino, Marina Chiara

Martelli, Olga

Bettini, Anna

Floriani, Irene

Copreni, Elena

Lauricella, Calogero

Ganzinelli, Monica

Marabese, Mirko

Broggini, Massimo

Veronese, Silvio

Gherardi, Giorgio

Longo, Flavia

Fabbri, Maria Agnese

Tomirotti, Maurizio

Alabiso, Oscar

Sarobba, Maria Giuseppa

Labianca, Roberto

Marsoni, Silvia

Farina, Gabriella

Scanni, Alberto

机构：

[1] AO Fatebenefratelli & Oftalm, UO Oncol Med, Milan, Italy

[2] San Giovanni Addolorata Hosp, Div Med Oncol, Rome, Italy

[3] Osped Riumiti Bergamo, Bergamo, Italy

[4] Ist Ric Farmacol Mario Negri, Lab Clin Trials, Milan, Italy

[5] Azienda Osped Niguarda Ca Granda, Milan, Italy

[6] Azienda Osped Fatebenefratelli & Oftalm, Dept Pathol, Milan, Italy

[7] Ist Ric Farmacol Mario Negri, Mol Pharmacol Lab, Milan, Italy

[8] Osped Niguarda Ca Granda, Dept Pathol, Milan, Italy

[9] Osped Fatebenefratelli & Oftalm, Dept Pathol, Milan, Italy

[10] Policlin Umberto I La Sapienza, Dept Med Oncol, Rome, Italy

[11] Osped Belcolle, Div Oncol, Rome, Italy

[12] Osped Maggiore Policlin, UO Oncol Med Fdn IRCCS Ca Granda, Milan, Italy

[13] Azienda Osped Maggiore della Carita, Novara, Italy

[14] Azienda Osped Univ Sassari, Sassari, Italy

[15] Osped Riuniti Bergamo, Dept Oncol, I-24100 Bergamo, Italy

[16] SENDO Fdn, Milan, Italy

[17] Osped Fatebenefratelli & Oftalm, Dept Oncol, Milan, Italy

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期

关键词：

D O I：

10.1200/jco.2012.30.18_suppl.lba7501

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

LBA7501

引用

页数：1